Institutional investors purchased a net $5.2 million shares of EXAS during the quarter ended March 2017 and now own 87.13% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
HANDELSBANKEN FONDER AB Bought 170.0 Thousand shares of Exact Sciences Corp
SVENSKA HANDELSBANKEN AB (DENMAR... Bought 56.1 Thousand shares of Exact Sciences Corp
C WORLDWIDE ASSET MANAGEMENT FON... Bought 30.9 Thousand shares of Exact Sciences Corp